Cargando…
Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method
AIMS: Amplification of the human epidermal growth factor receptor 2 (HER2) gene has been reported in gastric carcinoma (GC). Accordingly, trastuzumab plus chemotherapy has recently become the new standard treatment for HER2-positive advanced GCs. The aim was to compare the alleged gold standard for...
Autores principales: | García-García, Elena, Gómez-Martín, Carlos, Angulo, Bárbara, Conde, Esther, Suárez-Gauthier, Ana, Adrados, Magdalena, Perna, Cristian, Rodríguez-Peralto, José Luis, Hidalgo, Manuel, López-Ríos, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166662/ https://www.ncbi.nlm.nih.gov/pubmed/21771023 http://dx.doi.org/10.1111/j.1365-2559.2011.03894.x |
Ejemplares similares
-
Fully Automated RNAscope In Situ Hybridization Assays for Formalin‐Fixed Paraffin‐Embedded Cells and Tissues
por: Anderson, Courtney M., et al.
Publicado: (2016) -
Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer
por: Park, Kyeongmee, et al.
Publicado: (2011) -
In situ hybridization protocols /
Publicado: (2006) -
Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens
por: García-Caballero, Tomás, et al.
Publicado: (2010) -
Molecular Pathology—In Situ Hybridization
por: Sterchi, Diane L.
Publicado: (2008)